HomeAI · summaries
Storia in 7 fonti
Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial
The interim Phase I trial data was only from 35 people, but results look good so far.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Early data for heart drug affirm Lilly’s billion-dollar bet on Verve
The base editing medicine lowered “bad” cholesterol levels along with a key protein, clearing the way for a Phase 2 study.
- ·
benzinga.com
Chamath Palihapitiya Said This To Eli Lilly's Gene Therapy That Slashes LDL Cholesterol Up To 62% - Eli L
Chamath Palihapitiya reacted on X after Eli Lilly's VERVE-102 showed strong Phase 1b LDL cholesterol reduction results.
- ·
spectator.com
Gene-editing drugs are opening a new frontier in medicine
Medicines that we take only a few times and which permanently alter the trajectory of our lives for the better, are on the way.
- ·
medpagetoday.com
So Far, So Good for PCSK9-Targeting Gene Therapy in Hypercholesterolemia
Tweaked lipid nanoparticle delivery system showed early safety
- ·
arstechnica.com
Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial
The interim Phase I trial data was only from 35 people, but results look good so far.
- ·
One dose of gene-editing drug cut bad cholesterol 62% for months in small trial
The interim Phase I trial data was only from 35 people, but results look good so far.
- ·
time.com
A One-Time Experimental Treatment Might Control Cholesterol for Life
If it continues to work in further studies, a gene therapy in development could eliminate the need for daily pills or regular injections.
- ·
abcnews.com
New drug could be game changer for people with high cholesterol
Drugmaker Eli Lilly is testing a new experimental drug that could be a game changer for treating high cholesterol.